chartexchange

Niagen Bioscience Inc Reports Q3 2026 Loss of $(0.01) Per Share and Revenue of $27. ...

GuruFocus | Nov 4, 2026 4:39 PM EST

Net loss per share of $(0.01) compared with analyst estimates of $0.02; cash position strengthens to $69.5 million Related Stocks: NAGE ,

Read original article